Tebipenem pivoxil hydrobromide, an orally bioavailable prodrug of tebipenem, is currently in development for the treatment of complicated urinary tract infections. The spectrum of tebipenem activity against Enterobacterales is consistent with intravenous carbapenems such as ertapenem and meropenem including extended spectrum beta-lactamase (ESBL) and AmpC producing organisms. The goal of these studies was to determine the tebipenem exposure required to prevent on-therapy resistance and to evaluate the tebipenem regimen utilized in the recent Phase 3 clinical trial.Escherichia coli clinical isolates  (tebipenem MIC = 0.008 to 0.03 mg/L) were subjected to concentration-time profiles simulating free-drug plasma concentrations after oral administration of tebipenem regimens in a hollow-fiber in vitro infection model. Dose-ranging studies were completed using two isolates at an initial burden of 108 CFU/mL and with exposures for tebipenem regimens ranging from 4.69 to 1200 mg administered every eight hours (q8h). An additional isolate was subjected to only the tebipenem 600 mg q8h regimen evaluated in the Phase 3 trial. Samples were collected for the enumeration of bacterial burdens and evaluation of the simulated pharmacokinetic profile. Each sample for bacterial enumeration was suspended onto drug-free and tebipenem-supplemented agar plates in order to observe the density of the total- and drug-resistant subpopulations over the 10-day period.Three E. coli isolates. Tebipenem consistently lowered bacterial burdens below that of the initial inoculum at a dose of 600 mg q8h for all three E. coli isolates. Amplification of resistance was observed intermittently for all regimens, but was never equal to that of the total population at the 600 mg q8h clinical dose. Tebipenem MIC values for isolates collected from the drug-supplemented agar ranged from 0.06 to 0.25 mg/L, representing four two-fold dilutions from baseline.A full dose response, ranging from treatment failure to reductions in bacterial burden from baseline, were observed in the dose-ranging studies for the two These data support the selection of tebipenem dosing regimens that minimize the potential for on-therapy drug-resistance amplification.Brian D. VanScoy, B.S., 3-V Biosciences (Grant/Research Support)Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC (Grant/Research Support)Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Grant/Research Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC (Grant/Research Support)Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support) Haley Conde, B.S., 3-V Biosciences (Grant/Research Support)Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC (Grant/Research Support)Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Grant/Research Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC (Grant/Research Support)Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support) Sean Jones, B.S., 3-V Biosciences (Grant/Research Support)Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC (Grant/Research Support)Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Grant/Research Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC (Grant/Research Support)Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support) Ian A. Critchley, Ph.D., Spero Therapeutics  Thomas R. Parr, Ph.D., Spero Therapeutics  Nicole Cotroneo, Spero Therapeutics  Paul G. Ambrose, Pharm.D., FIDSA, 3-V Biosciences (Grant/Research Support)Achogen (Grant/Research Support)Amplyx Pharmaceuticals, Inc. (Grant/Research Support)Arixa Pharmaceuticals (Grant/Research Support)Arsanis Inc. (Grant/Research Support)B. Braun Medical Inc. (Grant/Research Support)Basilea Pharmaceutica (Grant/Research Support)BLC USA (Grant/Research Support)Boston Pharmaceuticals (Grant/Research Support)Bravos Biosciences, LLC Cidara Therapeutics Inc. (Grant/Research Support)Cipla, USA (Grant/Research Support)Corcept Therapeutics (Grant/Research Support)Cumberland Pharmaceuticals (Grant/Research Support)Debiopharm International SA (Grant/Research Support)Discuva Limited (Research Grant or Support)Emerald Lake Technologies (Grant/Research Support)Enhanced Pharmacodynamics (Grant/Research Support)Entasis Therapeutics (Grant/Research Support)E-Scape Bio (Grant/Research Support)Genentech (Grant/Research Support)Geom Therapeutics, Inc. (Grant/Research Support)GlaxoSmithKline (Grant/Research Support)Hoffmann-La Roche (Grant/Research Support)Horizon Orphan LLC (Grant/Research Support)ICPD Biosciences, LLC Indalo Therapeutics (Grant/Research Support)Insmed Inc. (Grant/Research Support)Institute for Clinical Pharmacodynamics (Employee)Iterum (Grant/Research Support)KBP Biosciences USA (Grant/Research Support)Kyoto Biopharma, Inc. (Grant/Research Support)Matinas (Grant/Research Support)Meiji Seika Pharma Co., Ltd. (Grant/Research Support)Melinta Therapeutics (Grant/Research Support)Menarini Ricerche S.p.A. (Grant/Research Support)Merck & Co., Inc (Grant/Research Support)Mutabilis (Grant/Research Support)Nabriva Therapeutics AG (Grant/Research Support)Naeja-RGM Pharmaceuticals (Grant/Research Support)Nosopharm SAS (Grant/Research Support)Novartis Pharmaceuticals Corp. (Grant/Research Support)NuCana Biomed (Grant/Research Support)Paratek Pharmaceuticals, Inc. (Grant/Research Support)Polyphor, Ltd. (Grant/Research Support)Prothena Corporation (Grant/Research Support)PTC Therapeutics (Grant/Research Support)Rempex Pharmaceuticals (Grant/Research Support)Roche TCRC (Grant/Research Support)Sagimet (Grant/Research Support)scPharmaceuticals Inc. (Grant/Research Support)Scynexis (Grant/Research Support)Spero Therapeutics (Grant/Research Support)TauRx Therapeutics (Grant/Research Support)Tetraphase Pharmaceuticals (Grant/Research Support)Theravance Biopharma Pharmaceutica (Grant/Research Support)USCAST (Grant/Research Support)VenatoRx (Grant/Research Support)Vical Incorporated (Grant/Research Support)Wockhardt Bio AG (Grant/Research Support)Zavante Therapeutics (Grant/Research Support)Zogenix International (Grant/Research Support)


Scientific Reports 10.1038/s41598-021-96483-5, published online 23 August 2021Correction to: The original version of this Article contained an error in the Funding section.“This study was supported by a research grant from the Korean Healthcare Technology R&D project funded by the Ministry of Health and Welfare  and a CMB-Yuhan research grant of Yonsei University College of Medicine (6-2019-0124).”now reads:“This study was supported by a research grant from the Korean Healthcare Technology R&D project funded by the Ministry of Health and Welfare  and a CMB-Yuhan research grant of Yonsei University College of Medicine (6-2019-0124).”The original Article has been corrected.


Scientific Reports6: Article number: 1880310.1038/srep18803; published online: 01252016; updated: 05222018The Acknowledgements section in this Article is incomplete.“The authors acknowledge funding from the Italian Ministry of Education, University and Research (MIUR) through the project “The global virtual-water network: social, economic, and environmental implications” (FIRB - RBFR12BA3Y).”should read:“The authors acknowledge funding from the Italian Ministry of Education, University and Research (MIUR) through the project “The global virtual-water network: social, economic, and environmental implications” (FIRB - RBFR12BA3Y). Funding from the European Research Council (ERC) is also acknowledged .”


Scientific Reports6: Article number: 3183210.1038/srep31832; published online: 08262016; updated: 05042017In the original version of this Article, Affiliations 1 and 2 were not listed in the correct order. The correct affiliations are listed below:Affiliation 1School of Psychology & Neuroscience University of St. Andrews, South Street, St Andrews, Fife KY16 9JP, United Kingdom.Affiliation 2School of Experimental Psychology University of Bristol 12a, Priory Road, Bristol BS8 1TU, United Kingdom.This error has now been corrected in the PDF and HTML versions of the Article.


Correction to:Oncogene (2017) 36, 1537–1545; doi:10.1038/onc.2016.320; published online 3 October 2016Following the publication of this article the authors note that they inadvertently omitted the correct acknowledgement for the support from the NIH and The Carl and Roberta Deutsch Foundation for the above referenced paper.The corrected acknowledgement should read:We acknowledge The Carl and Roberta Deutsch Foundation (PI: Farias-Eisner), Kelly Day, and NIH/NCI U54CA143930 Grant (PI: Farias-Eisner) for their financial support. We thank Professor Oliver Dorigo, Stanford University Medical Center, for the generous gift of cisplatin-resistant ovarian cancer cell lines. We thank Dr Xiangming Ding, UCLA Clinical Microarray Core, for the statistical assistance.The authors apologise for any inconvenience caused by this error.


Scientific Reports7: Article number: 4262810.1038/srep42628; published online: 02162017; updated: 05032017The Acknowledgements section in this Article is incomplete.“This work was supported by National Natural Science Foundation Project (81522013), Chongqing Outstanding Youth Grant (cstc2014jcyjjq10005), Chongqing Key Laboratory of Ophthalmology , Chongqing Science & Technology Platform and Base Construction Program (cstc2014pt-sy10002), National Key Clinical Specialties Construction Program of China and Research and Cultivation Foundation Project of Chongqing Medical University (201407)”.Should read:“This work was supported by National Natural Science Foundation Project , Chongqing Outstanding Youth Grant (cstc2014jcyjjq10005), Chongqing Key Laboratory of Ophthalmology , Chongqing Science & Technology Platform and Base Construction Program (cstc2014pt-sy10002), National Key Clinical Specialties Construction Program of China, Chongqing Graduate Student Research Innovation Project (CYB16096) and Research and Cultivation Foundation Project of Chongqing Medical University (201407)”.


Scientific Reports6: Article number: 2558210.1038/srep25582; published online: 05092016; updated: 09142016This Article contains errors in the Acknowledgements section.“This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2058053), and Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government(MSIP) . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript”.should read:“This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2058053), and the MSIP, Korea and Microsoft Research, under ICT/SW Creative research program supervised by the IITP(Institute for Information & Communications Technology Promotion) (IITP-2015- R-20150826-002098)”.


This article has been corrected: The correct Funding information is given below:FUNDINGNIH grant support in the Comprehensive Flow Cytometry Core (CFCC) (P30 AR48311), Dr. Londono is funded by a NIH Research Training Program in Basic and Translation Oncology T32 Grant (T32CA183926). Dr. Arend is supported by the Foundation for Women’s Cancer (WeRoc/OChO Ovarian Cancer Research Grant), Norma Livingston Foundation, AAOGF/ABOG Career Development Award, and ACS-IRG (IRG-60-001-53-IRG). Dr. Hidalgo is supported by the NHLBI Diversity Supplement (HHSN268201300001) and a grant from the Robert Wood Johnson Foundation, New Connections Program.https://doi.org/10.18632/oncotarget.13466Original article: Oncotarget. 2016; 7:86803-86815.


Scientific Reports 10.1038/s41598-017-01819-9, published online 12 May 2017Correction to: This Article contains typographical errors in the Acknowledgements section.“We gratefully acknowledge the support of the National Institutes of Health (NIH)-National Institute on Drug Abuse (NIDA) grants R01 DA036154; R21 DA041287 to NEH and DA041749 to MN and National Institutes of Health (NIH)-National Institute on Mental Health (NIMH) R01 MH110262 to FK.”should read:“We gratefully acknowledge the support of the National Institutes of Health (NIH)-National Institute on Drug Abuse (NIDA) grants R01 DA036154; R21 DA041287 to NEH and DA034547 to MN and National Institutes of Health (NIH)-National Institute on Mental Health (NIMH) R01 MH110262 to FK.”


Nature Communications 10.1038/s41467-017-01360-3, Article published online 3 November 2017Correction to: The original version of this Article omitted an affiliation of Cheng Hon Alfred Huan: ‘Institute of Materials Research and Engineering (IMRE), A*STAR, 2 Fusionopolis Way, Innovis #08-03 138634, Singapore’.This has now been corrected in both the PDF and HTML versions of the article.


This article has been corrected: the funding information statement was updated and is as follows:FUNDINGThis work was supported by grant of the Municipal Medical Key Discipline of Chongqing (YuWeiKeJiao No. 2007-2), and by grant of Integrated Demonstration Project of Chongqing Science and Technology Commission (cstc2015jcsf10008-1).https://doi.org/10.18632/oncotarget.18602Original article: Oncotarget. 2017; 8:53531-53541.


Scientific Reports7: Article number: 4374310.1038/srep43743; published online: 03082017; updated: 04102017This Article contains errors in the Acknowledgements section.“This work was supported by a Czech-Israel cooperative research grant issued by the Israel Ministry of science (grant number 3–9814) and the Czech Ministry of education (Grant LH13256 VES13-KontaktII). Additional support was given by the Czech Ministry of Health (Grant IGA MZ CR NT12282-5/2011) and the Charles University in Prague (Research Project PRVOUK-P26/LF1/4).”Should read:“This work was supported by the Czech Science Foundation (grant GACR 16-13323S) and by the Czech-Israel cooperative research grant ”.


Nature Communications7 Article number: 10833 ; DOI: 10.1038/ncomms10833 (2016). Published 03012016; Updated 08142017Technical support for this Article was not fully acknowledged. The Acknowledgements should have included the following: We thank Drs Ronald Petralia and Ya-Xian Wang, members of the Advanced Imaging Core, National Institute of Deafness and other Communication Disorders (NIDCD), for the images in Fig. 1k, l.


Scientific Reports 10.1038/s41598-017-07871-9, published online 08 August 2017Correction to: The Acknowledgements section in this Article is incomplete.“This study was supported by the National Key Research and Development Program of China (2016YFD0101007) to Dr. Ke-de Liu, the Natural Science Foundation of Hubei Province (36116006), and the Scientific & Technological Self-innovation Foundation of Huazhong Agricultural University (0900206305) to Dr. Cheng Dai. We are grateful to Dr. Qijun Chen for kindly providing pKSE401 and pCBC-DT1T2. We thank Dr. Chunying Kang, Dr. Robert M. Larkin and Dr. Liang Guo  for helpful discussion and critical reading of the manuscript.”should read:“This study was supported by the National Key Research and Development Program of China (2016YFD0101007) to Dr. Ke-de Liu, the Fundamental Research Funds for the Central Universities (No. 2662015BQ031) and the Natural Science Foundation of Hubei Province (No. 2016CFB141) to Dr. Cheng Dai. We are grateful to Dr. Qijun Chen for kindly providing pKSE401 and pCBC-DT1T2. We thank Dr. Chunying Kang, Dr. Robert M. Larkin and Dr. Liang Guo  for helpful discussion and critical reading of the manuscript.”


The funding statement should have read as follows:In the article “Design and fabrication of complete dentures using CAD/CAM technology”,This study was funded by the Clinical Support of PLA General Hospital (2014FC-SXYY-1003) and the Capital's Special Health Development Research (2014-4-5022).


Scientific Reports 10.1038/s41598-017-08223-3, published online 29 August 2017Correction to: The Acknowledgements section in this Article is incomplete.“This research was supported by the European Research Council (ERC StG CACTUS 312292) and the Swedish Research Council (2014-1156).”should read:“This research was supported by the European Research Council (ERC StG CACTUS 312292 and MSCA ITN Brainview 642996) and the Swedish Research Council (2014-1156).”


Nature Communications7: Article number: 13749; DOI: 10.1038/ncomms13749 (2016); Published: 12132016; Updated: 01202017The financial support for this Article was not fully acknowledged. The Acknowledgements should have included the following:This work was supported by the National Science Foundation Graduate Research Fellowship ; NSF IGERT 0734683 (S.D.S.); Christopher and Dana Reeve Paralysis Foundation (S.I.R. and K.V.S.); and the following to K.V.S.: Burroughs Welcome Fund Career Awards in the Biomedical Sciences, Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery N66001-10-C-2010, US National Institutes of Health Institute of Neurological Disorders and Stroke Transformative Research Award R01NS076460, US National Institutes of Health Director's Pioneer Award 8DP1HD075623-04, US National Institutes of Health Director's Transformative Research Award (TR01) from the NIMH #5R01MH09964703, and Defense Advanced Research Projects Agency NeuroFAST award from BTO #W911NF-14-2-0013.


In the original publication of this article , the funThe final funding statement can be found below:FundingThis work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) grants to IZ , NSERC Alexander Graham Bell Canada Graduate Scholarship-Doctoral (CGS-D) to RJ (#454402-2014), NSERC Alexander Graham Bell Canada Graduate Scholarship-Masters (CGS-M) to SC (#442618-2013), and an NSERC Undergraduate Student Research Award (USRA) to JB (#483630-2015). Work on the NGS platform of the Institut Curie was supported by the Agence Nationale de la Recherche (ANR Investissement d’Avenir) (ANR-10-EQPX-03) and by the France Génomique National infrastructure (ANR-10-INBS-09). The funding bodies had no role in study design, data collection, data analysis and interpretation, or preparation of the manuscript.


Scientific Reports 10.1038/s41598-017-11037-y, published online 31 August 2017Correction to: This Article contains an error in the Acknowledgements section.“Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology (2016YXMS215), Wuhan, China.”should read:“National Natural Science Foundation of China .”


Scientific Reports 10.1038/s41598-017-01458-0, published online 02 May 2017Correction to: The original version of this Article omitted an affiliation for Jian Lu. The correct affiliations are listed below:Department of Mechanical and Biomedical Engineering, City University of Hong Kong, Tae Chee Avenue Kowloon, Hong Kong 999077, China.Center for Advanced Structural Materials, City University of Hong Kong Shenzhen Research Institute, 8 Yuexing 1st Road, Nanshan District, Shenzhen, China.In addition, the Acknowledgements section in this Article contained errors:“The authors gratefully acknowledge the financial support of the ITER-National Magnetic Confinement Fusion Program (2010GB109000 and 2014GB123000). J. LU acknowledges the financial support provided by the MOST 973 Program of China under the grant 2012CB932203 and the Croucher Foundation Grant (CityU9500006).”now reads:“The authors gratefully acknowledge the financial support of the ITER-National Magnetic Confinement Fusion Program (2010GB109000 and 2014GB123000). J. LU acknowledges the financial support from Guangdong Science and Technology Department (Ref: 2014B050504003) and SZSTI (Ref: ZDSYS201602291653165).”These errors have now been corrected in the HTML and PDF versions of this Article.


Information is missing from the Funding section. Yashpal S. Kanwar was also a recipient of National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US)(NIHNIDDK)RO1DK60635. The correcting Funding Disclosure Statement should read as follows: This work was supported by the following sources of funding: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(US) (NIHNIDDK)RO1DK097240, Recipient: Janardan K. Reddy; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIHNIDDK)RO1 DK083163, Recipient: Janardan K. Reddy; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US)(NIHNIDDK)RO1DK60635, Recipient: Yashpal S Kanwar; and National Institutes of Health (US), National Institute of Allergy and Infectious Diseases(NIH) (AI)R21AI1094296, Recipient: Bayar Thimmapaya.


Scientific Reports 10.1038/s41598-018-20626-4, published online 01 February 2018Correction to: The original version of this Article contained an error in Affiliation 2 which was incorrectly listed as ‘MRAM Center, Department of Electronics and Computer Engineering, Hanyang University, Seoul, 04763, Republic of Korea’.The correct affiliation is listed below:‘MRAM Center, Department of Nanoscale Semiconductor Engineering, Hanyang University, Seoul, 04763, Republic of Korea.’In addition, the Acknowledgements section in this Article contained an error.“This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A1A01006474) and Brain Korea 21 PLUS Program in 2014.”now reads:“This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2A1A05001285) and Brain Korea 21 PLUS Program in 2014.”These errors have now been corrected in the PDF and HTML versions of the Article.


Scientific Reports 10.1038/s41598-017-09223-z, published online 18 August 2017Correction to: This Article contains typographical errors in the Acknowledgements section.“This is contribution  of the University of Maryland Center for Environmental Science, Chesapeake Biological Laboratory.”should read:“This is contribution 5394 of the University of Maryland Center for Environmental Science, Chesapeake Biological Laboratory.”


Scientific Reports 10.1038/s41598-018-22218-8, published online 28 February 2018Correction to: The Acknowledgements section in this Article is incomplete.“This work was supported by a National Research Foundation of Korea (NRF) grant by the Korean government .”should read:“This work was supported by a National Research Foundation of Korea (NRF) grant by the Korean government  and grant No 04-2016-0540 from the SNUH Research Fund.”


The Funding statement is incorrect. The correct statement is: This work was supported by Ministry of Higher Education FRGS grant (FP012-2015A) and University of Malaya Prototype Research Grant Scheme (PR002-2015B).


Nature Communications8 Article number: 15855 ; DOI: 10.1038/ncomms15855 (2017); Published: 06272017; Updated: 08072017The financial support for this Article was not fully acknowledged. The Acknowledgements should have included the following:This research used resources of the Advanced Light Source and the Stanford Synchrotron Radiation Lightsource, which are DOE Office of Science User Facilities under contract no. DE-AC02-05CH11231 and DE-AC02-76SF00515, respectively. The SSRL Structural Molecular Biology Program is supported by the DOE BER, and by the NIH (including P41GM103393). The SIBYLS beamline 12.3.1 is supported by the IDAT program from the DOE BER and the NIH project MINOS (R01GM105404).


Scientific Reports 10.1038/s41598-018-22655-5, published online 15 March 2018Correction to: The Acknowledgements section in this Article is incomplete.“The work was partially supported by National Science Foundation of China (61603209), and Beijing Natural Science Foundation (4164086), and the Study of Brain-Inspired Computing System of Tsinghua University program (20151080467), and Ministry of Education, Singapore, under contracts RG28/14, MOE2014-T2-1-028 and MOE2016-T2-1-119. Part of this work is an outcome of the Future Resilient Systems project at the Singapore-ETH Centre (SEC), which is funded by the National Research Foundation of Singapore (NRF) under its Campus for Research Excellence and Technological Enterprise (CREATE) programme.”should read:“The work was partially supported by National Science Foundation of China , and Beijing Natural Science Foundation (4164086), and the Study of Brain-Inspired Computing System of Tsinghua University program (20151080467), and SuZhou-Tsinghua innovation leading program 2016SZ0102, and Ministry of Education, Singapore, under contracts RG28/14, MOE2014-T2-1-028 and MOE2016-T2-1-119. Part of this work is an outcome of the Future Resilient Systems project at the Singapore-ETH Centre (SEC), which is funded by the National Research Foundation of Singapore (NRF) under its Campus for Research Excellence and Technological Enterprise (CREATE) program.”


Background: We investigated causal effect of completed growth, measured by adult height, on coronary heart disease (CHD), stroke and cardiovascular traits, using instrumental variable (IV) Mendelian randomization meta-analysis.Methods: We developed an allele score based on 69 single nucleotide polymorphisms (SNPs) associated with adult height, identified by the IBCCardioChip, and used it for IV analysis against cardiovascular risk factors and events in 21 studies and 60 028 participants. IV analysis on CHD was supplemented by summary data from 180 height-SNPs from the GIANT consortium and their corresponding CHD estimates derived from CARDIoGRAMplusC4D.Results: IV estimates from IBCCardioChip and GIANT-CARDIoGRAMplusC4D showed that a 6.5-cm increase in height reduced the odds of CHD by 10% ,which agrees with the estimate from the Emerging Risk Factors Collaboration . IV analysis revealed no association with stroke . IV analysis showed that a 6.5-cm increase in height resulted in lower levels of body mass index (P < 0.001), triglycerides (P < 0.001), non high-density (non-HDL) cholesterol (P < 0.001), C-reactive protein (P = 0.042), and systolic blood pressure (P = 0.064) and higher levels of forced expiratory volume in 1 s and forced vital capacity (P < 0.001 for both).Conclusions: Taller individuals have a lower risk of CHD with potential explanations being that taller people have a better lung function and lower levels of body mass index, cholesterol and blood pressure. All participating studies obtained informed consent for DNA analysis and received ethical approval.We included individual participant data from 60 028 participants of European ancestry from 21 prospective studies  Broad Institute CARe consortium (IBC) CardioChip arrayIJE online).We selected 69 SNPs, representing 69 different loci, independently associated with adult height at array-wide significance (P < 2.4×10−6) in gene-centric meta-analysis of height from 114 223 individuals and 47 studies genotyped with the IBC Cardiochip array  to construct the allele score.2 > 0.8) with those from IBC Cardiochip.Genotyping was conducted with the IBC Cardiochip array in 16 studies,IJE online.The primary outcome was prevalent or incident  CHD. The secondary outcome was prevalent or incident  stroke including haemorrhagic or ischaemic events. Validated events were preferred over non-validated, self-reported events. Details for outcome definitions in each study are provided in IJE online] and on lung function  given the established association with adult height.To gain insight into the mechanisms that may explain the association of height with CHD and stroke, we used available information from individual studies on established or promising risk factors for CHD and stroke .The IBC array data  Candidate Gene Association Resource (CARe) was downloaded with appropriate permissions from The database of Genotypes and Phenotypes (dbGaP) [http://www.mesa-nhlbi.org].CARe (Candidate gene Association Resource). The CARe Consortium wishes to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research (NHLBI contract number HHSN268200960009C). The following nine parent studies have contributed parent study data, ancillary study data and DNA samples through the Massachusetts Institute of Technology-Broad Institute (N01-HC-65226) to create this genotype/phenotype database for wide dissemination to the biomedical research community: the Atherosclerosis Risk in Communities (ARIC) study, the Cardiovascular Health Study (CHS), the Cleveland Family Study (CFS), the Cooperative Study of Sickle Cell Disease (CSSCD), the Coronary Artery Risk Development in Young Adults (CARDIA) study, the Framingham Heart Study (FHS), the Jackson Heart Study (JHS), the Multi-Ethnic Study of Atherosclerosis (MESA) and the Sleep Heart Health Study (SHHS). The ARIC study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The authors thank the staff and participants of the ARIC study for their important contributions. MESA was conducted and supported by contracts N01-HC-95159 through N01-HC-95169 and RR-024156 from the National Heart, Lung, and Blood Institute (NHLBI). The authors thank the participants of the MESA study, the Coordinating Center, MESA investigators and study staff for their valuable contributions. A full list of participating MESA investigators and institutions can be found at: [EAS (Edinburgh Artery Study). EAS is funded by the British Heart Foundation (Programme Grant RG/98002), with Metabochip genotyping funded by a project grant from the Chief Scientist Office of Scotland (Project Grant CZB/4/672).ELSA . ELSA is funded by the National Institute on Aging in the US  and by a consortium of UK Government departments involved in areas related to the ageing process . ELSA was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute of Fiscal Studies. The data were collected by the National Centre for Social Research.EPIC-NL (European Prospective Investigation into Cancer and Nutrition in The Netherlands). The EPIC-NL study was funded by ‘Europe against Cancer' Programme of the European Commission (SANCO), Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch Cancer Society, ZonMW, The Netherlands Organisation for Health Research and Development and World Cancer Research Fund (WCRF) (The Netherlands). Genotyping was funded by IOP Genomics grant IGE05012 from Agentschap NL.ET2DS is funded by the Medical Research Council (Project Grant G0500877), the Chief Scientist Office of Scottish (Programme Support Grant CZQ/1/38), Pfizer plc (Unrestricted Investigator Led Grant) and Diabetes UK . Research clinics were held at the Wellcome Trust Clinical Research Facility and Princess Alexandra Eye Pavilion in Edinburgh.LURIC was supported by the 7th Framework Program  of the European Union and by the INTERREG IV Oberrhein Program  with support from the European Regional Development Fund (ERDF) and the Wissenschaftsoffensive TMO. NORDIL (Nordic Diltiazem study). The NORDIL clinical study was supported by a grant from Pharmacia. Genetic studies were supported by the British Heart Foundation  and European Union Ingenious HyperCare Consortium: Integrated Genomics, Clinical Research, and Care in Hypertension (grant number LSHM-C7-2006-037093). Genotyping was supported by the British Heart Foundation (grant number PG/07/131/24254 to P.B.M.). We thank Prof. Thomas Hedner  and Prof. Sverre Kjeldsen , who are investigators of the NORDIL study.PROCARDIS (Precocious Coronary Artery Disease). The PROCARDIS consortium genotyping was funded by the British Heart Foundation (BHF) and EC Sixth Framework Programme (LSHM-CT-2007-037273) and the sample collection by AstraZeneca AB and the BHF. R.C., M.F. and H.W. are supported by the BHF Centre for Research Excellence; M.F. and H.W. acknowledge support from a Wellcome Trust core award (090532/Z/09/Z). R.C. acknowledges support from the MRC; Anders Hamsten obtained support for this project from the Swedish Heart-Lung Foundation, the Swedish Medical Research Council (8691), the Knut and Alice Wallenberg Foundation, the Karolinska Institute and the Stockholm County Council (560183).UCLEB . The UCLEB consortium is funded by a British Heart Foundation programme grant (ref RG/10/12/28456).WHI . The WHI programme is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221.WHII . The WHII study is supported by grants from the Medical Research Council , British Heart Foundation (RG/07/008/23674), Stroke Association, National Heart Lung and Blood Institute (5RO1 HL036310), National Institute on Aging (5RO1AG13196) Agency for Health Care Policy Research (HS06516), and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. We gratefully thank the subjects and the investigators of this project.The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Conflict of interest: Anke H Maitland-van der Zee has an unrestricted research grant for research on pharmacogenetics from GSK. All other primary authors declare no conflicts of interest.Key MessagesObservational studies show associations of adult height with risk of coronary heart disease (CHD) and stroke; however, these associations could arise from confounding or reverse causalityTo investigate the causal effect, we conducted a multi-locus Mendelian randomization study incorporating data from 180 height-related SNPs using both individual participant data from prospective cohorts and summary data from large genetics consortiaA 6.5-cm increase in adult height (instrumented by 180 SNPs) causally reduced the odds of CHD by 10%, with potential mechanisms including blood pressure, body mass index and non-HDL cholesterol; the effect of adult height on stroke was less clear.Supplementary DataClick here for additional data file.


Nature Communications 10.1038/s41467-018-04291-9, published online: 10 May 2018Correction to: The original version of this Article omitted an affiliation of Xiewen Wen: ‘College of Chemistry and Molecular Engineering, Beijing National Laboratory for Molecular Sciences, Peking University, Beijing 100871, China’. This has been corrected in both the PDF and HTML versions of the Article.


Scientific Reports 10.1038/s41598-017-08585-8, published online 18 August 2017Correction to: This article contains an error in the Acknowledgements section.“This work was supported in part by the Core-to-Core Program A. Advanced Research Networks and the Grants-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science.”should read:“This work was supported in part by the Core-to-Core Program A. Advanced Research Networks and the Grants-in-Aid for Scientific Research (A) (JP17H01277) and (B) (JP16H03878) from the Japan Society for the Promotion of Science.”


The following information is missing from the Funding section: This project was supported by the National Funds through FCT—Portuguese Foundation for Science and Technology (UID/DTP/04045/2013)—and the European Fund for regional development (FEDER) allocated by European Union through the COMPETE 2020 Programme (POCI-01-0145-FEDER-006969).


Scientific Reports 10.1038/s41598-018-20660-2, published online 09 February 2018Correction to: The Acknowledgements section in this Article is incomplete.“The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. This work was supported by National Heart, Lung, and Blood Institute training grant T32 predoctoral fellow T32HL007055.”should read:“The authors thank the staff and participants of HCHS/SOL (Investigators website - http://www.cscc.unc.edu.libproxy.lib.unc.edu/hchs/), NHANES, and the Coronary Artery Risk Development in Young Adults Study (CARDIA) for their important contributions. CARDIA is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201300025C & HHSN268201300026C), Northwestern University (HHSN268201300027C), University of Minnesota (HHSN268201300028C), Kaiser Foundation Research Institute (HHSN268201300029C), and Johns Hopkins University School of Medicine (HHSN268200900041C). CARDIA is also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. This work was supported by National Heart, Lung, and Blood Institute training grant T32 predoctoral fellow T32HL007055.”


Scientific Reports7: Article number: 45697; 10.1038/srep45697 published online: 04062017; updated: 07152017.The Acknowledgements section in this Article is incomplete.“This study was funded by the Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences , the Special Fund for Agro-Scientific Research in the Public Interest, China (grant no. 201303143) and the China Agriculture Research System (grant no. CARS-12)”.should read:“This study was funded by the Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences , the Special Fund for Agro-Scientific Research in the Public Interest, China (grant no. 201303143) and the China Agriculture Research System (grant no. CARS-12)”.


Scientific Reports 10.1038/s41598-017-15454-x, published online 10 November 2017Correction to: The Acknowledgements section in this Article is incomplete.“This work was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, HI14C1607 (S-HC), an NIH/NEI RO1-EY014878 and an unrestricted grant from RPB, Inc. (JMW).”should read:“This work was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, HI14C1607 and by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (No. 2017R1A2B4012327) (S-HC), an NIH/NEI RO1-EY014878 and an unrestricted grant from RPB, Inc. (JMW).”


Scientific Reports 10.1038/s41598-018-19592-8, published online 19 January 2018Correction to: This Article contains an error in Figure 1 where panels C and D are reversed. The correct Figure 1 appears below as Figure Additionally, this Article contains errors in the Methods section under subheading ‘Lipid extraction and UHPLC-MS/MS analyses of sterols and oxysterols’.TM or 6500TM; AB SCIEX, Ontario, Canada) equipped with atmospheric pressure chemical ionization (APCI).”“Analysis of sterols and oxysterols were performed by UHPLC-MS/MS using a triple-quadrupole mass spectrometer ; AB SCIEX, Ontario, Canada) equipped with atmospheric pressure chemical ionization (APCI).”“MS conditions: spray voltage, 5000 V; curtain gas, 10 psi; ion source gas, 20 psi; collision gas, high; entrance potential, 10 V; collision energy, 25 V; declustering potential, 80.00 V; temperature, 300 °C.”should read:“MS conditions: declustering potential, 80 V; entrance potential, 10 V; collision energy, 25 V; collision cell exit potential, 20.0 V. APCI parameters: nebulizer current, 3 mA; temperature, 300 °C; curtain gas, 10 psi for 4000™ and 20 psi for 6500™; ion source gas, 20 psi for 4000™and 55 psi for 6500™.”Finally, the Acknowledgements section in this Article is incomplete.“This work was supported, in part: by U.S.P.H.S. (NIH) grants R01 EY007361 (SJF), R00 HD073270 (LX), and R01 HD092659 (LX); by Clinical and Translational Science Award UL1 TR001412 to the University at Buffalo-The State University of New York from NCATS/NIH (SJF); by a Foundation Fighting Blindness Center Grant  (NSP); by a Research to Prevent Blindness Unrestricted Grant to the Department of Ophthalmology, University at Buffalo-The State University of New York from Research to Prevent Blindness (SJF); by startup funds from the Department of Medicinal Chemistry, School of Pharmacy, University of Washington (LX); and by facilities and resources provided by the VA Western New York Healthcare System (SJF) and the Louis Stokes Cleveland VA Medical Center (NSP).”should read:“This work was supported, in part: by U.S.P.H.S. (NIH) grants R01 EY007361 (SJF), R00 HD073270 (LX), and R01 HD092659 (LX); by Clinical and Translational Science Award UL1 TR001412 to the University at Buffalo-The State University of New York from NCATS/NIH (SJF); by a Foundation Fighting Blindness Center Grant (an unrestricted award) to the Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (NSP); by Research to Prevent Blindness Unrestricted Grants to the Departments of Ophthalmology, University at Buffalo-The State University of New York and the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University from Research to Prevent Blindness ; by startup funds from the Department of Medicinal Chemistry, School of Pharmacy, University of Washington (LX); and by facilities and resources provided by the VA Western New York Healthcare System (SJF) and the Louis Stokes Cleveland VA Medical Center (NSP).”


Gong and Lin was given incompletely. The full affiliation for these authors should read as follows: Department of Oral and Maxillofacial Oncology Surgery, Stomatological Medical Center, The First Affiliated Hospital of Xinjiang Medical University.In the article “Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis”,


Present: The grant number information is incorrect in the Acknowledgments.Correct: The proper grant information appears below:ACKNOWLEDGMENTSThis research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2014R1A1A2055411).18541-18557. doi: 10.18632/oncotarget.8105Original article: Oncotarget. 2016; 7:


Scientific Reports7:1610; doi: 10.1038/s41598-017-01647-x; Article published online 03 May 2017The original version of this Article contained an error in the author list where the authors Tiffanie Stewart and Chooda Khanal were inadvertently combined.The affiliations of Tiffanie Stewart and Chooda Khanal are:“Department of Electrical Engineering Florida International University, Miami, Florida, 33174, USA”This has now been corrected in the HTML and PDF versions of this Article.


Scientific Reports 10.1038/s41598-017-10148-w, published online 29 August 2017Correction to: The Acknowledgements section in this Article was omitted. The Acknowledgements section should read:“This research was supported by IBS-R023-D1 and the Global Frontier Project (2014M3A6B3063710) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. It was also supported by the Korea Health Technology R&D Project (HI14C0748) funded by the Ministry of Health and Welfare, Republic of Korea.”


Nature Communications 10.1038/s41467-017-02354-x, published online: 02 Jan 2018.Correction to: In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following:The National Basic Research Program (2015CB553602 to J.L.), the National Natural Science Foundation of China  and Tianjin Applied Basic and Frontier Tech Major Project (12JCZDJC34400 to J.L.) and Tianjin Higher Education Sci-Tech Development Project (20112D05 to J.L.).


The authors of this published article  would li“This study was funded by the US President’s Malaria Initiative (PMI) through the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00, managed by University Research Co., LLC (URC).”


Natural sea salt consumption confers protection against hypertension and kidney damage in Dahl salt-sensitive rats. Food & Nutrition Research. 61:1:1-10. When this article originally published online, the Acknowledgements section was incorrect. This has now been changed to read as follows:This research was supported by the Globalization of Korean Foods R&D Program , and by the Chung-Ang University Research Grants in 2015.


Scientific Reports 10.1038/s41598-017-01411-1, published online 03 May 2017Correction to: This Article contains an error in the Acknowledgements section.“This study was supported by research funding from NCI R01 CA164225 (L.W.), Advancing A Healthier Wisconsin Research and Education Program (AHW REP) fund (L.W.), Ann’s Hope Foundation from the Medical College of Wisconsin Cancer Center (L.W.), the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Cancer Research Program under Award No. W81XWH-14-1-0587 (L.W.), Worldwide Cancer Research Foundation (UK) research grant 16-1161 (L.W.).”should read:“This study was supported by research funding from NCI R01 CA164225 (L.W.), Advancing A Healthier Wisconsin Research and Education Program (AHW REP) fund (L.W.), Ann’s Hope Foundation from the Medical College of Wisconsin Cancer Center (L.W.), the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Cancer Research Program under Award No. W81XWH-14-1-0587 (L.W.), Worldwide Cancer Research (UK) research grant 16-1161 (L.W.).”


Scientific Reports 10.1038/s41598-017-17776-2, published online 13 December 2017Correction to: This Article contains typographical errors in the Acknowledgements section.“This work was supported by grants from the Catalan Diabetes Association (NT), University of Barcelona (NT), Carlos III Health Institute (ISCIII) PI17/00108 co-funded by FEDER funds/European Regional Development Fund (ERDF)-“a Way to Build Europe” (EM) and by CIBERDEM which is a project of ISCIII. The authors thank the CRG Genomics and Bioinformatics facilities.”should read:“This work was supported by grants from the Catalan Diabetes Association (NT), University of Barcelona (NT), Carlos III Health Institute (ISCIII) PI16/00462 co-funded by FEDER funds/European Regional Development Fund (ERDF)-“a Way to Build Europe” (EM) and by CIBERDEM which is a project of ISCIII. The authors thank the CRG Genomics and Bioinformatics facilities.”


Scientific Reports6: Article number: 3349110.1038/srep33491; published online: 09262016; updated: 12192016The Acknowledgements section in this Article is incomplete.“This work was supported by the Fonds der Chemischen Industrie and the Free State of Bavaria. The authors gratefully acknowledge financial support by the German Plastics Center SKZ and Julius-Maximilians Universität Würzburg for start-up funding. Light-scattering experiments were possible through support of the Deutsche Forschungsgemeinschaft (INST 93/774-1 FUGG). RL, CF and JG thank the Deutsche Forschungsgemeinschaft (LU 1571/9-1 and GA 2051/1-1 respectively) for the financial support of their respective research stay at the University College London. GB and LM thank the support of the ERC-STG-MEVIC grant for funding the work and their salary.”should read:“This work was supported by the Fonds der Chemischen Industrie and the Free State of Bavaria. The authors gratefully acknowledge financial support by the German Plastics Center SKZ and Julius-Maximilians Universität Würzburg for start-up funding. Light-scattering experiments were possible through support of the Deutsche Forschungsgemeinschaft (INST 93/774-1 FUGG). RL, CF and JG thank the Deutsche Forschungsgemeinschaft (LU 1571/9-1 and GA 2051/1-1 respectively) for the financial support of their respective research stay at the University College London. GB and LM thank the support of the ERC-STG-MEVIC grant for funding the work and their salary. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.”


In the article titled “Time-Shift Correlation Algorithm for P300 Event Related Potential Brain-Computer Interface Implementation” , an acknThe authors would like to thank the Ministry of Science and Technology (under Grant MOST 104-2221-E-011-140) and the Taipei Medical University/National Taiwan University of Science and Technology cross-university collaboration project (under Grant TMU-NTUST-103-07) for partial support of this work.


Complexes of the diuretic benzothiadiazine derivative chlorothiazide  with V(IV); Fe(II); Co(II); Ni(II); Cu(II), Ag(I) and U(VI) wereprepared and characterized by elemental analysis, spectroscopic, thermogravimetric, magnetic andconductimetric measurements. The complexes behave as effective inhibitors for two isozymes (I and II) ofcarbonic anhydrase (CA).


Metal complexes of the title ligand (L) containing Co(II), Ni(II) and Cu(II) were prepared andcharacterized by elemental analysis, IR, electronic spectroscopy and conductimetry. The new derivatives,possessing the following formulae, CuL


The title compound was prepared by an improved variant of the literature procedure, and metal complexes containing its anion and the following metal ions: Zn(II), Cd(II), Hg(II), Co(II), Ni(II), Cu(II), V(IV), Fe(III) and Ag(I) were synthesized and characterized by standard procedures . The parent sulfonamide and its metal complexes are potent inhibitors of two carbonic anhydrase (CA) isozymes, CA I and II, and they might possess applications as selective cerebrovasodilating agents.


Correction to: Blood Cancer Journal (2018) 8: 6810.1038/s41408-018-0103-6;Published online 19 July 2018MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UKNIHR Oxford Biomedical Research Centre, Oxford, UKSince the publication of the original article the authors noticed the the affiliation details for Paresh Vyas are incorrect. The correct affiliation details for this author are given below:


Nature Communications 10.1038/s41467-018-07467-5; published online 03 December 2018Correction to: The original version of this Article contained errors in the author affiliations.Affiliation 2 incorrectly read ‘Department of Biochemistry and Molecular Genetics and Breast Surgery, Ehime University Graduate School of Medicine, 7910295, Japan’ and affiliation 3 incorrectly read ‘Department of Hepato-Biliary-Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Matsuyama 7910295, Japan.’These errors have now been corrected in both the PDF and HTML versions of the Article.


This article has been corrected: The correct Acknowledgments and Funding information is given below:ACKNOWLEDGMENTS AND FUNDINGThis study was supported by grants from the Ministry of Science and Technology , the Kaohsiung Medical University “Aim for the Top 500 Universities Grant” (Grant No. KMU-TP105C05), the Kaohsiung Medical University “Aim for the Top Journals Grant” (Grant No. KMU-DT106005), and the Kaohsiung Medical University Hospital Research Foundation (KMUH106-6R13).https://doi.org/10.18632/oncotarget.21022Original article: Oncotarget. 2017; 8:104831-104854.


Scientific Reports 10.1038/s41598-017-11606-1, published online 11 September 2017Correction to: The Acknowledgements section in this Article is incomplete.“This work was supported by Malta Council of Science and Technology, grant R&I-2013-14 EPILEFREE to GDG. RC was supported by fellowship funded by EPILEFREE.”should read:“This work was supported by Malta Council of Science and Technology, grant R&I-2013-14 EPILEFREE to GDG. RC was supported by fellowship funded by EPILEFREE. MP was supported by a Research Officer Fellowship from the Faculty of Medicine and Surgery, University of Malta. The authors acknowledge the practical contribution of doctoral student Ms Maria Vella.”


Scientific Reports 10.1038/s41598-018-30578-4, published online 13 August 2018Correction to: The Acknowledgements section in this Article is incomplete.“LR is supported by Finep (1355/10) and CNPq (202077/2015-2). GP is supported by FAPESP (2014/06863-3) and CNPq (441878/2014-8). The Villum Center for Bioanalytical Sciences at University of Southern Denmark is acknowledged for access to advanced mass spectrometric instrumentation.”should read:“LR is supported by Finep (1355/10) and CNPq (202077/2015-2). GP is supported by FAPESP (2014/06863-3) and CNPq (441878/2014-8). The Villum Center for Bioanalytical Sciences at University of Southern Denmark is acknowledged for access to advanced mass spectrometric instrumentation.Prof. Gilberto B. Domont and Prof. Fabio C.S. Nogueira from the Federal University of Rio de Janeiro, Brazil are acknowledged for critical discussion during the revision of the paper.”


Scientific Reports 10.1038/s41598-017-09543-0, published online 29 August 2017Correction to: The Acknowledgements section in this Article is incorrect.“This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (No. 2015M3A9E2028643).”should read:“This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (Grant No. 2012–049729)”.


Scientific Reports 10.1038/s41598-019-50000-x, published online 19 September 2019Correction to: The Acknowledgements section in this Article is incomplete.“Work at Brookhaven National Laboratory was supported by US DOE, Office of Science, Office of Basic Energy Sciences under contract DE-SC0012704.”should read:“This work was funded by the Computation Material Science Program (Y.L. and C.P.). TEM studies at Brookhaven National Laboratory were supported by US DOE, Office of Science, Office of Basic Energy Sciences under contract DE-SC0012704.”


Scientific Reports 10.1038/s41598-017-18851-4, published online 12 January 2018Correction to: The Acknowledgements section in this Article is incomplete.“We thank Mr. N. K. Skamangas for technical support and Dr. A. Kovoor for the D2 receptor expression plasmid, Dr. H. Itoh for GαoA and Dr. N. Lambert for sharing the Gβγ-Venus constructs. This work was supported by NIH grants DA036596 and DA026405 (KAM). MYN is supported by Israel Science Foundation grant 432/12 and Chief Scientist Ministry of Health (the ERA-NET network) and grant no. 3-9543 from the Chief Scientist Office of the Ministry of Health, Israel via the ERA-net network. MK is supported by Israel Science Foundation grant numbers 1454/13, 1959/13, 2155/15. YS is supported by the Israel Science Foundation grant numbers 1604/13 and 877/13, the ERC (StG-335377), by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. Lady Davis Fellowship to ADP is gratefully acknowledged. NKH and RAS are supported by fellowships from the National Health and Medical Research Council of Australia.”should read:“We thank Mr. N. K. Skamangas for technical support and Dr. A. Kovoor for the D2 receptor expression plasmid, Dr. H. Itoh for GαoA and Dr. N. Lambert for sharing the Gβγ-Venus constructs. This work was supported by NIH grants DA036596 and DA026405 (KAM). MYN is supported by Israel Science Foundation grant 432/12 and Chief Scientist Ministry of Health (the ERA-NET network) and grant no. 3-9543 from the Chief Scientist Office of the Ministry of Health, Israel via the ERA-net network. MK is supported by Israel Science Foundation grant numbers 1454/13, 1959/13, 2155/15. YS is supported by the Israel Science Foundation grant numbers 1604/13 and 877/13, the ERC (StG-335377), The Minerva Foundation Grant, by the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. Lady Davis Fellowship to ADP is gratefully acknowledged. NKH and RAS are supported by fellowships from the National Health and Medical Research Council of Australia.”


Correction to: BMC Med Inform Decis Makhttps://doi.org/10.1186/s12911-018-0696-5After publication of this supplement article , it was The correct affiliation of the first and correspondence authors is ‘Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, China’.


Nancy Bennett, University of Rochester Medical Center, and Monica Farley, Veterans Affairs Medical Center and Emory University Department of Medicine.In the report “Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices,” on page 1074, the ACIP Pneumococcal Vaccines Work Group should have included


Scientific Reports 10.1038/s41598-018-29524-1, published online 10 September 2018Correction to: This Article contains typographical errors in the Acknowledgements section.“This work was supported by the National Natural Science Foundation of China (No. 21677071) and the Jiangsu Natural Science Foundation .”should read:“This work was supported by the National Natural Science Foundation of China (No. 21677071) and the Jiangsu Natural Science Foundation .”


Scientific Reports 10.1038/s41598-018-30851-6, published online 22 August 2018Correction to: The Acknowledgements section in this Article is incomplete.“This work was supported by Sao Paulo Research Foundation, (FAPESP) grant 2009/53904-9 and grant 2012/15165-2, Experimental Therapeutic Laboratory I (LIM 20), School of Medicine, University of Sao Paulo, School of Medicine Foundation (FFM/USP) and Financial Assistance to Educational Project or Research (AUXPE/PROAP) grant 2696/2013.”should read:“This work was supported by Sao Paulo Research Foundation, (FAPESP) grants 2009/53904-9, 2012/15165-2 and 2018/20380-6, Experimental Therapeutic Laboratory I (LIM 20), School of Medicine, University of Sao Paulo, School of Medicine Foundation (FFM/USP) and Financial Assistance to Educational Project or Research (AUXPE/PROAP) grant 2696/2013.”


Correction to: Acta neuropathol commun (2019) 7: 4https://doi.org/10.1186/s40478-018-0654-6Alzheimer Society Research Program (ASRP) from the Alzheimer Society of Canada” was missing. In this correction article the updated funding acknowledgement is shown. The missing funding acknowledgement has been indicated in bold.In the original publication of this article , the funThe Dementia Research Centre is supported by Alzheimer’s Research UK, Brain Research Trust, and The Wolfson Foundation. This work was supported by the NIHR Queen Square Dementia Biomedical Research Unit and the NIHR UCL/H Biomedical Research Centre, the MRC UK GENFI grant and the Alzheimer’s Society.IFH is funded by a research grant from Eli Lilly and Company, and the Engineering and Physical Sciences Research Council (EPSRC) UK (EP/N034864/1).JMO’C is funded by UK Medical Research Council (MRC) Doctoral Training Grant Studentship (MR/J500422/1).LC is funded by an unrestricted grant from OPTOS Plc. Ltd.and a proportion of funding from the Alzheimer Society of Canada through the Alzheimer Society Research Program (ASRP).DM received a proportion of funding from EPSRC studentship from UCL’s Centre for Doctoral Training in Medical Imaging, JDR is supported by an MRC Clinician Scientist Fellowship (MR/M008525/1) and has received funding from the NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH).MFL receives funding from BBSRC/AstraZeneca Industrial Partnership Studentship (BB/E528979/1), the UK Regenerative Medicine Platform Safety Hub (MR/K026739/1), Eli Lilly and Company, and the EPSRC (EP/N034864/1).IL receives funding from the Bill Brown Charitable Trust, Moorfields Eye Hospital Special Trustees and Mercer Fund from Fight for Sight.


Nature Communications; 10.1038/s41467-019-08326-7; published online 29 January 2019.Correction to: The original version of this article incorrectly listed the present address of Bo Wu as ‘Present address: Institute of Electronic Paper Displays, South China Academy of Advanced Optoelectronics, South China Normal University, Guangzhou, Guangdong Province 510006, China’. This is the author’s primary affiliation. This has been corrected in both the PDF and HTML versions of the article.


Scientific Reports 10.1038/s41598-018-32298-1, published online 17 September 2018Correction to: The Acknowledgements section in this Article in incomplete.“S. Abate of CNR-SPIN Salerno is acknowledged for his valuable technical support. This work is partially supported by University of Salerno through grants FARB15PAGAN and FARB16CAVAL.”should read:“S. Abate of CNR-SPIN Salerno is acknowledged for his valuable technical support. This work is partially supported by University of Salerno through grants FARB15PAGAN and FARB16CAVAL.A.V.U. acknowledges partial support from the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of the National University of Science and Technology MISIS (Contract No. K2-2017-081).”


Nature Communications 10.1038/s41467-019-09737-2, published online 15 April 2019.Correction to: The original version of this Article contained an error in the Acknowledgements, which incorrectly omitted from the end the following: ‘J. Kang and L.W. Wang were supported by the Director, Office of Science, the Office of Basic Energy Sciences (BES), Materials Sciences and Engineering (MSE) Division of the U.S. Department of Energy (DOE) through the organic/inorganic nanocomposite program (KC3104) under contract DE-AC02-05CH11231. It used the computational resource of the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory through the INCITE project.’ This has been corrected in both the PDF and HTML versions of the Article.


Dr. Gelu Onose - 54 years ; graduated, in 1982, from the Faculty of General Medicine, within the (former) Institute of Medicine and Pharmacy, in BucharestProfessor at the (State) University of Medicine and Pharmacy (UMF) “Carol Davila”, in Bucharest, Romania - the M6 Chair- MD; - PhD; - MSc- Senior Physician of : - Physical & Rehabilitation Medicine (PRM) and- - Gerontology & Geriatrics (G-G)•Chief of the M6 Chair of the “C. Davila” UMF and of the PRM Discipline and of the Physical and  Rehabilitation Clinic Division of the UMF, at the Teaching Emergency Hospital “Bagdasar-Arseni” (TEHBA), in Bucharest•President/ Co-Founder of the Romanian Society for Neurorehabilitation (RoSNeRa) - affiliated to the World Federation for NeuroRehabilitation (WFNR) - member of its Management Committee - and respectively, of the Romanian Society for Spinal Cord Pathology, Therapy and Rehabilitation in SCI (RoSCoS) - affiliated to the Internationa Spinal Cord Society (ISCoS) and to the European Spinal Cord Injury Federation (ESCIF)•member of the Scientific Committee, afferent to the Prezidium of the World Academy for Multidisciplinary Neurotraumatology (AMN)A •Selected and invited by Thomson Reuters, to participate in the invitation-only Academic Reputation Survey”, within its related partnership with Times Higher Education's influential World University Rankings.(2010 and 2011)•Invitated Peer-Reviewer (in 2010) by the “Journal of Molecular Histology” (ISI Thomson Reuters rated)•A member of the Board of the Romanian Society of Physical and Rehabilitation Medicine•8 published medical books - one of them : “The Spondyloarthropathies”, and received, in 2002, the “Iuliu Hatieganu” Award of The Romanian Academy)•2 chapters within medical books•About 200 scientific works and papers - communicated within national and international scientific meetings and/or published in peer-reviewed or non peer-reviewed medical journals - and professional interviews/ articles, in mass-media•3 Invention Certificates, appointed by the State Office for Inventions and Marks•Gold Medal at the International Saloon of Inventions, Geneva/ Switzerland (2008)Main awards: the “Iuliu Hatieganu” Award of The Romanian Academy (2002); the Award of the (Romanian) National Authority for Scientific Research; the •member of the Editorial Board of medical journals:A •“Journal of Medicine and Life” •“Infomedica”•(Romanian) “Rehabilitation, Physical Medicine and Balneology”•“Romanian Neurosurgery”•Main co-organizer of the  National Conference of Neurosurgery and NeuroRehabilitation, with International participation


Nature Communications; 10.1038/s41467-019-08365-0; published online 25 January 2019Correction to: The original version of this Article contained an error in the author affiliations.Affiliation 5 incorrectly read ‘Laboratory for Prediction of Cell Systems Dynamics, RIKEN Center for Biosystems Dynamics Research (BDR), Suite, Hyogo 565-0874, Japan.’ This has now been corrected in both the PDF and HTML versions of the Article.


In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways” [In the article titled “athways” , a grantWe thank Morouge Alramadhan for technical support. We also thank the Universidad El Bosque for financial support for whole genome sequencing (Grant no. PCI-2017-9447). This work was supported by the National Institutes of Health (Grant nos. K08-AI113317 (TTT) and K24-AI121296 (CAA)), the Millennium Science Initiative of the Ministry of Economy, Development and Tourism, Government of Chile (JMM), and the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), FONDECYT 1171805, Ministry of Education, Government of Chile (JMM).


Correction to: Stem Cell Res Therhttps://doi.org/10.1186/s13287-015-0078-1The original article  containsAcknowledgementsThis work was supported by the Ministry of Science and Technology of China ; the National Natural Science Foundation of China ; National program for support of Top-notch young professionals (J.X.); Shanghai City, the medical cooperation projects (11DZ192130C); Projects of International Cooperation and Exchanges NSFC (81261130318); the Fundamental Research Funds for the Central Universities; Tongji University Talents Training Program (2011KJ051); New Century Excellent Talents in University (NCET-10-0606); 51th China Postdoctoral surface Project (2012 M510890); Shanghai Postdoctoral Research Funding Scheme of 2012 (12R21416200).


Scientific Reports 10.1038/s41598-018-36580-0, published online 28 January 2019Correction to: The Acknowledgements section in this Article is incomplete.“This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2017R1A2B2005081); and by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, & Future Planning (2016M3C7A1913844).”should read:“This research was supported by Research of Korea Centers for Disease Control and Prevention (2018-ER6203-01); the Brain Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1913844); the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (NRF-2017R1A2B2005081); and a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea(HI18C1629).”


Scientific Reports 10.1038/s41598-018-22300-1, published online 02 March 2018Correction to: The Acknowledgements section in this Article is incomplete.P. aeruginosa PA14 and pEX18Gm . We thank Shanghai Synchrotron Radiation Facility (SSRF) beamline BL17U for beamtime allowance. We thank the staffs of the National Center for Protein Sciences Shanghai (NCPSS) beamlines BL-18U and BL-19U and SSRF, Shanghai, People’s Republic of China, for assistance during data collection.”“We thank Matthew R Parsek for the gifts of should read:P. aeruginosa PA14 and pEX18Gm . We thank Shanghai Synchrotron Radiation Facility (SSRF) beamline BL17U for beamtime allowance. We thank the staffs of the National Center for Protein Sciences Shanghai (NCPSS) beamlines BL-18U and BL-19U and SSRF, Shanghai, People’s Republic of China, for assistance during data collection.”“The work was supported by National Natural Science Foundation of China (Grant Nos. 81670008 and 81501787) and National Key Research and Development Plan (Grant No. SQ2016YFJC040104). We thank Matthew R Parsek for the gifts of


Scientific Reports 10.1038/s41598-019-42237-3, published online 16 April 2019Correction to: The Acknowledgements section of this Article is incomplete.“Funded by NIH R21 CA184612-01 and Melanoma Research Foundation CDA Grant Award (A.V.). NIH R01 CA204806 (N.L.). We would like to acknowledge the important technical contributions and advice of Kimberlyn Acklin, MS, SCYM(ASCP), at The George Washington University Flow Cytometry Core Facility and Bethany Rentz, RVT, at The George Washington University Office of Animal Research.”should read:“Funded by NIH R21 CA184612-01 and Melanoma Research Foundation CDA Grant Award (A.V.), NIH R01 CA204806 (N.L.), Czech Science Foundation (No 15-19640S), the CAS (RVO: 86652036) and the project „BIOCEV” (CZ.1.05/1.1.00/02.0109) from the ERDF (C.B.). We would like to acknowledge the important technical contributions and the advice of Kimberlyn Acklin, MS, SCYM(ASCP), at The George Washington University Flow Cytometry Core Facility and Bethany Rentz, RVT, at The George Washington University Office of Animal Research.”


Scientific Reports 10.1038/s41598-017-05102-9, published online 07 July 2017Correction to: This Article contains typographical errors in the Acknowledgements section.“This study was supported by a BrightFocus Foundation grant M2015221 (MK), NIH grants EY023468 (WMD), EY0123456 (CBR), EY023287 (WDS), EY022359 (WDS), EY019696 (WDS), a Glaucoma Research Foundation Shaffer Grant , and a grant from the Foundation Fighting Blindness (CBR). A Core Grant for Vision Research  from NEI (to Duke University), supported much of the work, including the mass spectrometric analyses carried out by NPS.”should read:“This study was supported by a BrightFocus Foundation grant M2015221 (MK), NIH grants EY023468 (WMD), EY026161 (CBR), EY023287 (WDS), EY022359 (WDS), EY019696 (WDS), a Glaucoma Research Foundation Shaffer Grant , and a grant from the Foundation Fighting Blindness (CBR). A Core Grant for Vision Research  from NEI (to Duke University), supported much of the work, including the mass spectrometric analyses carried out by NPS.”


Scientific Reports 10.1038/s41598-019-46182-z, published online 08 July 2019Correction to: The original version of this Article omitted an affiliation for Ilona Wehl and Stefan Bräse. The correct affiliations for Ilona Wehl and Stefan Bräse are listed below:Institute of Organic Chemistry, Karlsruhe Institute of Technology (KIT), Fritz-Haber-Weg 6, D-76131 Karlsruhe, Germany.Institute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology (KIT), Hermann von Helmholtz Platz 1 D-76344 Eggenstein-Leopoldshafen, Germany.Additionally, in the Supplementary Information file originally published with this Article the treatment in Supplementary Figure S1 was incorrectly listed as CoQ Peptoid.These errors have now been corrected in the HTML and PDF versions of this Article, and in the accompanying Supplemental Material.


Scientific Reports 10.1038/s41598-018-30048-x, published online 17 August 2018Correction to: This Article contains typographical errors in the Acknowledgements section.“the 4th Three-year Action Plan for Public Health of Shanghai (15GWZK0101) from Shanghai Municipal Commission of Health and Family Planning”should read:“the 4th Three-year Action Plan for Public Health of Shanghai (GWTD2015S01) from Shanghai Municipal Commission of Health and Family Planning”


Scientific Reports 10.1038/s41598-018-23875-5, published online 03 April 2018Correction to: The Acknowledgements section in this article is incomplete:“We would like to thank Kyunghwa Han for her statistical advice. This study was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2014R1A1A2055116) and faculty research grants from Yonsei University College of Medicine (4-2013-0111).”should read:“We would like to thank Kyunghwa Han for her statistical advice. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2055116) and faculty research grants from Yonsei University College of Medicine (6-2013-0058).”


Two code files and one dataset related to Olympic Twitter activity are the foundation for this article. Through Twitter's Spritzer streaming API (Application Programming Interface), we collected over 430 million tweets from May 12th, 2016 to September 12th, 2016 windowing the Rio de Janeiro Olympics and Paralympics. We cleaned and filtered these tweets to contain Olympic-related content. We then analyzed the raw data of 21,218,652 tweets including location data, language, and tweet content to distill the sentiment and emotions of Twitter users pertaining to the Olympic Games Kassens-Noor E. et al., 2019. We generalized the original data set to comply with the Twitter's Terms of Service and Developer agreement, 2018. We present the modified dataset and accompanying code files in this article to suggest using both for further analysis on sentiment and emotions related to the Rio de Janeiro Olympics and for comparative research on imagery and perceptions of other Olympic Games. For example, The Olympic Games increase visibility of host cities and broadcast the host's imagery across the world 1.1Tweets were downloaded from Twitter's Application Program Interface (Spritzer Stream) from May 12th, 2016 to September 12th, 2016 based on Olympic Game keywords and associated hashtags. We searched for hashtags related to all modern Summer and Winter Olympic Games, but only the following captured tweets: Olympic (Olympics/#olympic/#olympics/Olympic Games/Olympic), Rio (Rio2016/#Rio2016), Tokyo (Tokyo2020/#Tokyo2020), London (London2012/#London2012), International Olympic Committee (IOC/#IOC), Los Angeles (LA2024/#LA2024), Beijing (Beijing2008/#Beijing2008/Beijing2022/#Beijing2022), Paris (Paris2024/#Paris2024), Sydney (Sydney2000/#Sydney2000), Budapest (Budapest2024/#Budapest2024), Atlanta (Atlanta1996/#Atlanta1996), Athens (Athens2004/#Athens2004), Rome (Rome2024/#Rome2024), Sochi (Sochi2014/#Sochi2014), Barcelona (Barcelona1992/#Barcelona1992), Seoul (Seoul1988/#Seoul1988), Vancouver (Vancouver2010/#Vancouver2010), Hamburg (Hamburg2024/#Hamburg2024), Turin (Turin2006/#Turin2006), Calgary , Salt Lake City , and Pyeongchang (Pyeongchang2018/#Pyeongchang2018).Code file Execute and associated Code file Argument filtered the captured tweets to (a) remove retweets and duplicate tweets (b) search for and record Olympic Game keywords for all remaining tweets (c) search for and record all Sentiment and emotion keywords for every tweet based on Mohammand and Turney's


Panel A) chest X-ray and (Panel B) transthoracic echocardiography, with echocardiographic features of early cardiac tamponade, including diastolic collapse of the right ventricular free wall  abnormal tracer uptake in the heart, particularly the right atrium (asterisk) and (Panel D) lytic bone lesions in the spine (asterisk). Cardiac magnetic resonance imaging demonstrated an epicardial mass encasing the heart, the right coronary artery (dashed arrow), and superior vena cava; (Panel E) four-chamber and (Panel F) short-axis steady-state free precession cine images. The mass had high-native T1 values, was vascular on first pass perfusion imaging (Panel G) gadolinium contrast, suggestive of a solid tumour. Pericardial biopsy demonstrated a diffuse polymorphic cellular infiltrate, consisting of lymphocytes, plasma cells, and numerous large multi-nucleated cells with ill-defined pale cytoplasm. These abnormal cells displayed (Panel H) emperipolesis (arrow) and stained positive for CD163 and (Panel I) S100 (arrow), but not CD1a or Langerin. The underlying diagnosis was Rosai–Dorfman disease; a rare idiopathic non-clonal proliferative histiocytic disorder that involves the heart in <1% of cases. Cardiac involvement in Rosai-Dorfman disease can present as epicardial disease, with pulmonary arterial involvement, or as an intracardiac mass.A 40-year-old man presented to hospital with exertional dyspnoea. A large pericardial effusion was identified by (J.M.T. was supported by the Wellcome Trust [211100/Z/18/Z] and the National Institute for Health Research. C.M. was supported directly and indirectly by the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and the National Institute for Health Research Barts Biomedical Research Centre. jey232_SuppClick here for additional data file.


The correct Material and Methods of the abstract is: Material and Methods: A total of 120 human premolars were randomly divided into two groups (n=60) according to the orthodontic adhesive used: APC Flash-Free Adhesive Coated Appliance System (APC FF) or Transbond PLUS Color Change Adhesive (TP), as control. A SBS test was performed and ARI value for each specimen was also assessed. Results were analyzed by two-way ANOVA and Tukey's Chi-square test (


Nature Communications; 10.1038/s41467-019-08506-5; published online 13 February 2019Correction to: The original version of this Article incorrectly omitted an affiliation of Kaikai Li: ‘Shenzhen Environmental Science and New Energy Technology Engineering Laboratory, Tsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Shenzhen 518055, China’. This has been corrected in both the PDF and HTML versions of the Article.


Nature Communications 10.1038/s41467-018-06088-2; published online 11 September 2018Correction to: The original version of this article incorrectly omitted an affiliation of Hongming Weng: “Beijing National Laboratory for Condensed Matter Physics and Institute of Physics, Chinese Academy of Sciences, 100190, Beijing, China”This has been corrected in both the PDF and HTML versions of the article.


Correction to: BMC Health Serv Res (2019) 19:743https://doi.org/10.1186/s12913-019-4578-zIn the original publication of this article , the autThe authors thank the Infection Prevention and Control (IPC) Program at Alberta Health Services for providing access to the IPC surveillance platform data.


Following publication of the original article , South Coast Perioperative Audit and Research Collaboration (SPARC).Clare M. Morkane


The following information is missing from the Funding section: This study was also funded by the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (BIRAC/BT/AIR0275/PACE-12/17).


Correction to: BMC Medical Genomics 2019, 12(Suppl 1):18.https://doi.org/10.1186/s12920-018-0460-9Following publication of the original article , the autThis research and this article’s publication costs were supported partially by the NCI Cancer Center Shared Resources (NIH-NCI P30CA54174 to YC), NIH , CPRIT (RP160732 to YC), and San Antonio Life Science Institute . AG is supported by the NIH/NCATS TL1 Translational Science Training award (TL1TR002647) and the AACR-AstraZeneca Stimulating Therapeutic Advances through Research Training grant. The funding sources had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.


Nature Communications 10.1038/s41467-018-06769-y; published online 23 October 2018Correction to: In the original PDF version of this article, affiliation 1, ‘Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum Muenchen & German Center for Diabetes Research (DZD), Neuherberg, Germany’, was incorrectly given as ‘Institute of Diabetes and Regeneration Research, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany ‘. This has now been corrected in the PDF version of the article; the HTML version was correct at the time of publication.


Correction to: Inflamm Regen (2017) 37:2010.1186/s41232-017-0051-8After publication of the original article , it cameIn addition, the following funding information should have been included as part of Declarations:“Sandesh Panthi was supported by Basic Science Research Program through the Korean National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning .”


This article has been corrected: The correct Grant number information is given below:ACKNOWLEDGMENTS AND FUNDINGThis work was supported by the Public Welfare Technology Application Research project of Zhejiang Provincial Science, Technology Department of China (Grant No. 2014C33198), Zhejiang Provincial Natural Science Foundation of China (Grant No. LY16H160015), National Natural Science Foundation of China , scientific research foundation of the ministry of public health (WKJ2012-2-009), Zhejiang province key project of science and technology (2014C04008-2).51773-51783. https://doi.org/10.18632/oncotarget.10575Original article: Oncotarget. 2016; 7:


This article has been corrected: The proper Grant Support information is shown below:This research was supported by a Department of Defense Prostate Cancer Research Program Early Investigator Research Award – Predoctoral (MS), Prostate Cancer Foundation Young Investigator Award (AML), Randy Shaver Foundation Research Award (AML), Paul Calabresi NCI K12 Award through Mayo Clinic (AML) and an American Cancer Society Institutional Research Grant (AML).36693-36704. https://doi.org/10.18632/oncotarget.26401Original article: Oncotarget. 2018; 9:36693–36704.


In the Acknowledgement section of the paper, “This study was supported in part by United States National Institutes of Health (NIH) Academic Research Enhancement Award 1R15GM114739 and National Institute of General Medical Sciences (NIH/NIGMS) 5P20GM103429, United States Food and Drug Administration (FDA) HHSF223201510172C through Arkansas Research Alliance (ARA) BAA-15-00121 and Arkansas Science and Technology Authority (ASTA) Basic Science Research 15-B-23 and 15-B-38” should read asNational Institutes of Health (NIH) Academic Research Enhancement Award 1R15GM114739 and National Institute of General Medical Sciences (NIH/NIGMS) 5P20GM103429, Arkansas Science and Technology Authority (ASTA) Basic Science Research 15-B-23 and 15-B-38 and the Food and Drug Administration (FDA), contract No. HHSF223201510172C and HHSF223201610111C. However, the information contained herein represents the position of the author(s) and not necessarily that of the NIH and FDA.”“This study was partially supported by United States The authors would like to apologise for any inconvenience caused.


Scientific Reports 10.1038/s41598-018-23497-x, published online 23 March 2018Correction to: The Acknowledgements section in this Article is incomplete.“This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (Grant No. 201504501), Zhejiang Xinmiao Talents Program (Grant No. 2018R46), Key Laboratory of Bio-based Material Science & Technology (Northeast Forestry University), Ministry of Education (Grant No. SWZCL2016-3) and Zhejiang Xinmiao Talents Program (Grant No. 2017R412011).”should read:“This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (Grant No. 201504501), Zhejiang Xinmiao Talents Program (Grant No. 2018R412047), Key Laboratory of Bio-based Material Science & Technology (Northeast Forestry University), Ministry of Education (Grant No. SWZCL2016-3) and Zhejiang Xinmiao Talents Program (Grant No. 2017R412011).”


Scientific Reports 10.1038/s41598-018-23407-1, published online 23 March 2018Correction to: This Article contains typographical errors in the Acknowledgements section.“We would like to thank all the research team members from Clinical Research Unit and clinical doctors from diabetes centre at Khoo Teck Puat Hospital, Singapore for assistance with participant recruitment and data input for the DN and SMART2D and follow-up study. This study was supported by Alexandra Health Enabling Grant (AHEG1504) and Small Innovation Grants (AHPL SIG I/13031 & STAR17109).”should read:“We would like to thank all the research team members from Clinical Research Unit and clinical doctors from diabetes centre at Khoo Teck Puat Hospital, Singapore for assistance with participant recruitment and data input for the DN and SMART2D and follow-up study. This study was supported by Alexandra Health Enabling Grant (AHEG1504), Small Innovation Grants (AHPL SIG I/13031 & STAR17109) and Singapore National Medical Research Council Grants (NMRC/PPG/AH (KTPH)/2011 and NMRC/CIRG/1398/2014).”


In the funding statement the following sentence was omitted:“This work was supported in part by NCI Cancer Systems Biology Center U54 CA209988.”The correct funding statement is as follows:www.nsfgrfp.org) and was supported by the Berkeley Fellowship for Graduate Study (grad.berkeley.edu) and the Tau Beta Pi Engineering Honors Society, Williams No. 35 (www.tbp.org). CJT and MPC were supported by the National Institutes of Health (NIH) Center “Systems Biology of Collective Cells Decisions” through Stanford University NIH #P50GM107615, and by the National Cancer Institute (NCI) CSBC consortia “Model-Based Predictions of Responses to RTK Pathway Therapies” through OHSU NCI #U54CA112970 and “Measuring, Modeling and Controlling Heterogeneity” through OHSU NCI #1U54CA209988-01A1. TR was supported by the Ruth L. Kirschstein T32 Program in Molecular and Cellular Biosciences Training Grant 5T32GM071338-09, Vertex Pharmaceuticals Scholarship (www.vrtx.com), and Tartar Trust Fellowship (www.ohsu.edu). EML was supported by the American Cancer Society Postdoctoral Fellowship (www.cancer.org). RCS is supported by the National Institutes of Health, National Cancer Institute R01-CA196228, R01-CA186241, and U54-CA209988, the Department of Defense Breast Cancer Research Program BC160550P1, the Colson Family Foundation , and the Prospect Creek Foundation . This work was supported in part by NCI Cancer Systems Biology Center U54 CA209988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.MPC is supported by a National Science Foundation Graduate Research Fellowship (


Correction to: J Hematol Oncolhttps://doi.org/10.1186/s13045-018-0658-5The original article  containsFundingThis work was supported by the grants from Kyung Hee University (KHU20170844 for JW Choi) and the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea .


Nature Communications 10.1038/s41467-019-10079-2, published online 9 May 2019.Correction to: The original version of this Comment contained errors in the legend of Figure 2, in which the locations of the fifteenth and sixteenth GBA members were incorrectly given as ‘(15) Australian Genome Foundry, Macquarie University; (16) Australian Foundry for Advanced Biomanufacturing, University of Queensland’. The correct version replaces this with ‘(15) Australian Foundry for Advanced Biomanufacturing (AusFAB), University of Queensland and (16) Australian Genome Foundry, Macquarie University’. This has been corrected in both the PDF and HTML versions of the Comment.


In the article titled “Serial Changes of Neointimal Tissue after Everolimus-Eluting Stent Implantation in Porcine Coronary Artery: An Optical Coherence Tomography Analysis” , a resea“This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (nos. A085012 and A102064), grants from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (no. A085136), and the Cardiovascular Research Center, Seoul, Republic of Korea, and a research grant from Yonsei University, College of Medicine (6-2011-00217).”


This article has been corrected: The correct Grant Support information is given below:GRANT SUPPORTThis study was financially supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2016R1D1A3B03930581 to YS Jeong), Medical Research Center Program (2017R1A5A2015369), Yonsei University Future-leading Research Initiative of 2015 (RMS2-2015-22-0094), JJ-2017-1 to YS Jeong, and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C0039).82491-82505. https://doi.org/10.18632/oncotarget.19700Original article: Oncotarget. 2017; 8:


The fourteenth author's name is spelled incorrectly. The correct name is: Patricia C. Salinas.The following information is also missing from the Funding statement: This study was supported by the MRC (MR/M024083/1) to PCS. The funding statement in full should read:This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/M020991/1) and New Life Foundation (14-15/20) to SC-S and PLB; ERC (AdG 695709 DENDRITECIRCUITS to MH and StG 678790 NEWRON to CS-H) and the Wellcome Trust (PRF 536070) to MH; MRC (MR/M024083/1) to PCS. Additional support was funded by National Institute for Health Research (GOS ICH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


Scientific Reports 10.1038/s41598-019-49654-4, published online 13 September 2019Correction to: The Acknowledgements section in this Article is incomplete.“We thank J. Warren for help with the scanning electron microscopy (SEM) measurement. Work at Brookhaven National Laboratory was supported by US DOE, Office of Science, Office of Basic Energy Sciences under contract DE-SC0012704.”should read:“We thank J. Warren for help with the scanning electron microscopy (SEM) measurement. This work was funded by the Computation Material Science Program (Y.L. and C.P.). TEM studies at Brookhaven National Laboratory were supported by US DOE, Office of Science, Office of Basic Energy Sciences under contract DE-SC0012704.”


In Silico Genome-Wide Analysis of the ATP-Binding Cassette Transporter Gene Family in Soybean (Glycine max L.) and Their Expression Profiling” [In the article titled “ofiling” , the AckThis work was financially supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agri-Bio Industry Technology Development Program and financially supported by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (117044-3).